FindTrial
Sign In

Observational Study on Serum Levels of Spleen Lesion Proviral Integration Proto-Oncogene (SPI1) in Patients with Coronary Heart Disease

Observational Study on Serum Levels of Spleen Lesion Proviral Integration Proto-Oncogene (SPI1) in Patients with Coronary Heart Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097911
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Coronary Heart Disease group:None
Non-Coronary Heart Disease group:None

Sponsors

Second Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-80 years; 2.Written informed consent obtained.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with malignancy; 2. Patients with pulmonary fibrosis; 3. Patients with hematologic disorders; 4. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Spleen Lesion Proviral Integration Proto-Oncogene;Interferon Regulatory Factor 8;Blood-lipid;Lower extremity vascular ultrasound;Coronary angiography;Coronary computed tomography angiography;—

Secondary

MeasureTime frame
Blood routine;coagulation function;D-dimer;Blood glucose;Markers of heart failure and myocardial infarction;Neck vascular ultrasound;—

Countries

China

Contacts

Public ContactJie Yang

Second Hospital of the Army Medical University

yangjie0818@hotmail.com+86 186 2333 0911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026